Why Unreviewed Failed Runs Happens and How QA Teams Should Control It


Published on 06/05/2026

Understanding and Managing Unreviewed Failed Runs in Chromatography Data Systems

In pharmaceutical manufacturing, especially within Quality Assurance and Quality Control practices, the occurrence of unreviewed failed runs in Chromatography Data Systems (CDS) can signal significant data integrity risks. These situations not only undermine the credibility of analytical results but can also lead to regulatory scrutiny and extend timelines for product release. In this article, we will explore how to effectively manage and control these risks through a structured approach involving investigation, root cause analysis, and corrective action.

By the end of this article, you will gain insights into detecting unreviewed failed runs, implementing immediate containment actions, performing comprehensive investigations, and establishing a control strategy to prevent recurrence. This practical guide aims to equip you with the necessary tools to maintain CDS data integrity and compliance with relevant regulatory standards such as 21 CFR Part 11 and ICH guidelines.

Symptoms/Signals on the Floor or in the Lab

Unreviewed failed runs can present themselves through various symptoms that may indicate underlying issues in the analytical process. Key signals

to watch for include:

  • Inconsistent Results: A batch may show variations that exceed acceptable limits, suggesting potential errors in data collection or interpretation.
  • Auditing Alerts: Automated alerts generated by the CDS indicating discrepancies in audit trails or the occurrence of failed analyses.
  • Staff Complaints: Feedback from laboratory personnel regarding difficulties in executing or interpreting results, especially in relation to system malfunctions.
  • Documentation Gaps: Observations of inadequate record-keeping on failed runs could highlight a lack of review or acknowledgment of problems.

Recognizing these signals promptly is critical for effective containment and investigation.

Likely Causes (by category: Materials, Method, Machine, Man, Measurement, Environment)

Identifying the root causes of unreviewed failed runs involves exploring multiple possible categories of failure. Below are potential causes segmented into six classifications:

Category Potential Causes
Materials Improper calibration standards, expired reagents, and contaminated samples.
Method Inadequate or poorly defined methods leading to inconsistent analysis protocols.
Machine Equipment malfunction, insufficient maintenance, and calibration issues with HPLC or GC systems.
Man Lack of training, human error in data entry, and non-compliance with SOPs.
Measurement Faulty or misconfigured CDS software and instrumentation errors.
Environment Inappropriate laboratory conditions, such as temperature fluctuations or contamination risks.

A comprehensive investigation should cover all these areas to ensure no stone is left unturned.

Immediate Containment Actions (first 60 minutes)

Upon identification of an unreviewed failed run, the first hour is critical for containment. Implement the following immediate actions:

  1. Isolate the Affected Batch: Immediately halt all analysis of the affected batch and any related materials until a thorough investigation is carried out.
  2. Document Initial Findings: Record all relevant details regarding the failure, including time, personnel involved, and initial observations.
  3. Notify Relevant Stakeholders: Inform the QA team, laboratory supervisors, and possibly regulatory representatives of the issue to ensure transparency and readiness for investigations.
  4. Preserve Data Integrity: Lock the relevant CDS files to prevent unauthorized changes or deletions while investigations are underway.
  5. Conduct Preliminary Checks: Verify system operation logs and any alarms from the CDS for evidence of prior failures or pattern trends.
Pharma Tip:  Inspection-Ready Approach to Peak Integration Changes in Pharmaceutical Operations

These immediate containment actions not only safeguard data integrity but also prepare the ground for root cause analysis.

Investigation Workflow (data to collect + how to interpret)

The investigation into unreviewed failed runs necessitates a meticulous approach to data collection and interpretation. Follow this structured workflow:

  • Gather Relevant Documentation: Collect all laboratory records, batch documentation, audit trail logs, and maintenance records for the CDS in question.
  • Interview Personnel: Conduct interviews with personnel who were involved during the run to obtain insights into potential human errors or misunderstandings.
  • Review Technological Logs: Analyze electronic logs from the CDS for insights into system performance before and during the failed run.
  • Benchmark Against Standards: Compare the collected data against established operating procedures and industry standards to identify deviations.
  • Identify Patterns: Look for trends or recurring issues across multiple failed runs to help pinpoint systematic versus isolated problems.

Interpreting this data should lead to informed decisions on the root causes and corrective actions necessary.

Root Cause Tools (5-Why, Fishbone, Fault Tree) and when to use which

Once data has been collected, employing root cause analysis tools is crucial for deeply understanding the underlying issues. Here are three effective methods:

  • 5-Why Analysis: This technique is useful for simple problems where identifying the immediate causal factor is sufficient. Ask “Why?” five times to drill down to the core issue.
  • Fishbone Diagram: Ideal for more complex problems, this tool categorizes potential causes into distinct areas (e.g., Man, Method, Machine) and visually maps out their relationships to the failure.
  • Fault Tree Analysis: Best suited for systems analysis, this deductive method involves graphically analyzing the pathways leading to the fault, helping identify both direct and contributing factors.

Selecting the appropriate tool hinges on the complexity of the unreviewed failed run and the scope of investigation required.

CAPA Strategy (correction, corrective action, preventive action)

Once the root causes have been identified, implementing an effective Corrective and Preventive Action (CAPA) strategy will ensure that the issue is fully resolved and does not recur. This involves:

  • Correction: Rectify any immediate issues that have been identified, such as re-running the analysis using validated methods and materials.
  • Corrective Action: Formulate actions aimed at addressing the root cause to prevent future occurrences. This may include revising standard operating procedures or improving training programs for personnel.
  • Preventive Action: Establish long-term monitoring and review processes, ensuring that audit trails and system alerts are employed effectively to catch potential failures early in the workflow.
Pharma Tip:  Chromatography Lab Inspection Readiness: Root Causes, GMP Risks, and CAPA Controls

Maintaining thorough documentation of the CAPA process is crucial for compliance and informing stakeholders of the resolution.

Control Strategy & Monitoring (SPC/trending, sampling, alarms, verification)

A robust control strategy is essential to monitor for signs of potential failures in the future. Here’s how to implement an effective control and monitoring framework:

  • Statistical Process Control (SPC): Utilize SPC tools to track variations in analytical processes and identify trends that may indicate deviations from established norms.
  • Regular Sampling: Implement routine sampling of all critical analysis runs, ensuring consistency in methodology and materials while reducing the probability of error.
  • Alarm Systems: Set up alarms within the CDS to provide real-time alerts for deviations in expected performance, allowing for prompt intervention.
  • Verification Processes: Establish systematic verification processes post-analysis to ensure the reliability of results and integrity of data before release.

These controls provide a framework for ongoing monitoring and exploitation of data integrity checking.

Related Reads

Validation / Re-qualification / Change Control impact (when needed)

Unreviewed failed runs may necessitate a comprehensive evaluation of your validation and change control processes. Assess whether:

  • Validation Requirements Are Met: Ensure that all systems remain validated according to current regulatory standards, especially following any incident that indicates possible data integrity issues.
  • Re-qualification: Analyze whether equipment, methods, or personnel require re-qualification post-failure to reaffirm their reliability and compliance.
  • Change Control Protocols Are Followed: Adhere to change control procedures for any adjustments to methods or equipment that may impact results based on findings from the investigation.

These evaluations are crucial to maintaining compliance with regulatory agencies while reinforcing the integrity of processes.

Inspection Readiness: what evidence to show (records, logs, batch docs, deviations)

Being prepared for inspection is vital following unreviewed failed runs. Ensure that the following documentation and evidence are readily available:

  • Audit Trail Logs: Present comprehensive logs from the CDS that clearly demonstrate the chronological order of all actions taken during the failed runs.
  • Batch Production Records: Provide thorough batch records that detail all steps taken within the manufacturing or analytical processes relevant to the failures.
  • Deviations Handling Records: Keep clear records of all deviations, including investigations and resolutions, evidencing adherence to QA protocols.
  • CAPA Documentation: Document all CAPA initiatives undertaken following the incident, demonstrating proactive management of data integrity risks.
Pharma Tip:  Step-by-Step Guide to Managing Sample Set Modification Under ALCOA+ Expectations

Maintaining organized and accessible documentation not only ensures regulatory compliance but also fosters a culture of transparency and continual improvement.

FAQs

What are unreviewed failed runs in CDS?

Unreviewed failed runs refer to analytical test results that have failed to be examined or validated within the Chromatography Data System, potentially jeopardizing data integrity.

What impact do unreviewed runs have on data integrity?

They compromise the reliability of the analytical results, which can lead to quality issues and regulatory violations if not contained and addressed swiftly.

How can I prevent unreviewed failed runs in my laboratory?

Implement rigorous training for staff, establish robust procedures for data review, and ensure strict adherence to SOPs during analyses.

What tools can help identify root causes of CDS failures?

Tools such as 5-Why analyses, Fishbone diagrams, and Fault Tree analyses can effectively dissect and identify root causes behind failures.

When should I trigger a CAPA?

A CAPA should be initiated whenever a non-conformance like an unreviewed failed run is identified, focusing on correction, corrective action, and preventive action.

How critical is inspection readiness after a failure?

Inspection readiness is crucial as regulators expect comprehensive documentation and evidence of managed risks and adherence to quality standards following such incidents.

What role does continuous monitoring play in preventing failures?

Continuous monitoring, including SPC and alarm systems, serves as a proactive measure to identify deviations and intervene before they escalate into larger issues.

What should I do if a failure occurs in a validated method?

Evaluate if the method remains valid, conduct a thorough investigation into potential causes, and implement appropriate corrective measures while ensuring compliance with regulatory expectations.

How often should I review CDS audit trails?

Regular reviews of CDS audit trails should be conducted, ideally during routine quality checks, with additional scrutiny following any anomalies or failed analyses.

What documentation is essential for responding to regulatory inspections?

Essential documentation includes audit trail logs, batch production records, CAPA responses, and detailed records of any deviations managed during the incident.

Can employee training impact the likelihood of failed runs?

Yes, comprehensive and ongoing training of employees increases their competency in handling systems, improves adherence to processes, and significantly reduces errors.

How does data integrity relate to the overall quality system?

Data integrity is a fundamental component of the overall quality management system, underpinning the validity of all processes and ensuring regulatory compliance.